Skip to content

Evommune EVMN Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect at other companies

Rumble, Inc. logo
Rumble, Inc.RUM
-$18.88M-110%
SkyWest logo
SkyWestSKYW
-$56.83M-17.4%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$443M+9,754%
Paycom Software logo
Paycom SoftwarePAYC
-$2.73B-65.4%
Lincoln Educational Services Corporation logo
Lincoln Educational Services CorporationLINC
-$11.83M+61.4%
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
-$62.01M-916%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+42.8%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect?
Evommune (EVMN) reported cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect of -$1.65M in Q1 2026.
What does cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect mean?
Represents the net change in the total balance of cash, cash equivalents, and restricted cash during the reporting period. This metric provides a high-level view of the company's overall liquidity position and cash flow health.